...
首页> 外文期刊>Chemistry & biology >Non-canonical Bromodomain within DNA-PKcs Promotes DNA Damage Response and Radioresistance through Recognizing an IR-Induced Acetyl-Lysine on H2AX
【24h】

Non-canonical Bromodomain within DNA-PKcs Promotes DNA Damage Response and Radioresistance through Recognizing an IR-Induced Acetyl-Lysine on H2AX

机译:DNA-PKcs中的非规范Bromodomain通过识别H2AX上的IR诱导的乙酰赖氨酸来促进DNA损伤反应和抗辐射性

获取原文
获取原文并翻译 | 示例
           

摘要

Regulatory mechanisms underlying gamma H2AX induction and the associated cell fate decision during DNA damage response (DDR) remain obscure. Here, we discover a bromodomain (BRD)-like module in DNA-PKcs (DNA-PKcs-BRD) that specifically recognizes H2AX acetyl-lysine 5 (K5ac) for sequential induction of gH2AX and concurrent cell fate decision( s). First, top-down mass spectrometry of radiation-phenotypic, full-length H2AX revealed a radiation-inducible, K5ac-dependent induction of gamma H2AX. Combined approaches of sequence-structure modeling/docking, site-directed mutagenesis, and biochemical experiments illustrated that through docking on H2AX K5ac, this non-canonical BRD determines not only the H2AX-targeting activity of DNA-PKcs but also the over-activation of DNA-PKcs in radioresistant tumor cells, whereas a Kac antagonist, JQ1, was able to bind to DNA-PKcs-BRD, leading to re-sensitization of tumor cells to radiation. This study elucidates the mechanism underlying the H2AX-dependent regulation of DNA-PKcs in ionizing radiation-induced, differential DDR, and derives an unconventional, non-catalytic domain target in DNA-PKs for overcoming resistance during cancer radiotherapy.
机译:伽马H2AX诱导和DNA损伤反应(DDR)期间相关的细胞命运决定的调控机制仍然不清楚。在这里,我们在DNA-PKcs(DNA-PKcs-BRD)中发现了一个类似溴结构域(BRD)的模块,该模块可特异性识别H2AX乙酰赖氨酸5(K5ac),用于顺序诱导gH2AX和并发的细胞命运决定。首先,辐射表型全长H2AX的自顶向下质谱分析显示了辐射诱导型K5ac依赖性的H2AX诱导。序列结构建模/对接,定点诱变和生化实验的组合方法表明,通过在H2AX K5ac上对接,这种非规范的BRD不仅决定了DNA-PKcs的H2AX靶向活性,而且还决定了H2AX的过度活化。放射抗性肿瘤细胞中的DNA-PKcs,而Kac拮抗剂JQ1能够与DNA-PKcs-BRD结合,从而导致肿瘤细胞对放射线重新敏感。这项研究阐明了电离辐射诱导的差异DDR中H2AX依赖的DNA-PKcs调控的基本机制,并推导了DNA-PKs中非常规的非催化结构域靶标,用于克服癌症放疗期间的耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号